Bibliography

Export 31 results:

Filters: Keyword is Hematopoietic Stem Cell Transplantation [Clear All Filters]

2013

Schubert A, Michel D, Mertens T. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation. BMC infectious diseases//BMC Infect Dis. 2013;13:223.

2010

Defabianis P, Braida S, Guagnano R. 180-day screening study for predicting the risk factors for developing acute oral Graft-versus-Host disease in paediatric patients subjected to allogenic haematopoietic stem cells transplantation. Eur J Paediatr Dent. 2010;11(1):31-4.

of on Bioethics A. Children as hematopoietic stem cell donors. Pediatrics. 2010;125(2):392-404.

Ljungman P, Hakki M, Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recipients. Infect Dis Clin North Am. 2010;24(2):319-37.

Mori T, Kato J. Cytomegalovirus infection/disease after hematopoietic stem cell transplantation. Int J Hematol. 2010;91(4):588-95.

Ljungman P. Molecular monitoring of viral infections after hematopoietic stem cell transplantation. Int J Hematol. 2010;91(4):596-601.

Peres RM, Costa CR, Andrade PD, Bonon SH, Albuquerque DM, de Oliveira C, et al. Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR. BMC Infect Dis. 2010;10:147.

2009

Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604-11.

2008

Kaul DR, Lowe L, Visvesvara GS, Farmen S, Khaled YA, Yanik GA. Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole. Transpl Infect Dis. 2008;10(6):437-41.

Haspel RL, Miller KB. Hematopoietic stem cells: source matters. Curr Stem Cell Res Ther. 2008;3(4):229-36.

Sullivan K, Jagannath S, Mazumder A, Vesole DH. Plasma exchange after hematopoietic stem cell transplantation in multiple myeloma to reduce renal insufficiency. Bone Marrow Transplant. 2008;42(11):767.

Pamphilon D, Nacheva E, Navarrete C, Madrigal A, Goldman J. The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors. Transfusion. 2008;48(7):1495-501.

2007

Calmels B, Lemarié C, Esterni B, Malugani C, Charbonnier A, Coso D, et al. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product. Transfusion. 2007;47(7):1268-75.

2006

Goldman JM, Madrigal AJ, Pamphilon D. Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors. Br J Haematol. 2006;135(5):651-2.

Gupta S, Jain A, Fanning TV, Couriel DR, Jimenez CA, Eapen GA. An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: a case report. BMC Cancer. 2006;6:87.

Kelly M, Roy DC, Labbe AC, Laverdiere M. What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria? Bone Marrow Transplant. 2006;38(3):183-8.

2005

Arimura K, Inoue H, Kukita T, Matsushita K, Akimot M, Kawamata N, et al. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica//Haematologica. 2005;90(3):ECR10.

2004

Pallera AM, Schwartzberg LS. Managing the toxicity of hematopoietic stem cell transplant. J Support Oncol. 2004;2(3):223-37; - discussion - 237-8, - 241, - 246-7.

2002

Bolan CD, Leitman SF. Management of anticoagulation-associated toxicity during large-volume leukapheresis of peripheral blood stem cell donors. Blood. 2002;99(5):1878.

2001

Moog R. Adverse events in peripheral progenitor cell collection: a 7-year experience. J Hematother Stem Cell Res. 2001;10(5):675-80.

2000

Zenhausern R, Tobler A, Leoncini L, Hess OM, Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol. 2000;79(9):523-6.

Chemnitz J, Fuchs M, Blau W, Hartmann P, Wickenhauser C, Scheid C, et al. Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation. Ann Hematol. 2000;79(9):527-9.

Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant. 2000;25(12):1299-301.

1999

LeBlanc R, Roy J, Demers C, Vu L, Cantin G. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant. 1999;23(10):991-6.

Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R, et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 1999;94(4):1465-70.

Pages